Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Charles River’s preclinical site suspension to cost 300 jobs

Monday, January 11th, 2010

Charles River Laboratories International Inc. has provided additional details regarding today’s announcement that the company is suspending operations at its Shrewsbury, Mass., preclinical facility in the middle of the year. According to the world’s third-ranked publicly traded CRO, 300 people will be laid off as a result of the move. ...

   
©2012 UBM Canon